| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |